12-Mar-2014 - The US FDA has chastised India-based Canton Laboratories for failing to offer raw data on previously submitted statistics in April 2013.
News in brief
11-Mar-2014 - Ireland remains a significant small molecule drug manufacturing hub the Industrial Development Agency (IDA) says, despite a number of API plant closures.
11-Mar-2014 - Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO.
10-Mar-2014 - Publication of a US FDA enforcement report detailing a recall by Ranbaxy in January saw the beleaguered Indian drugmakers’ share price fall 3% last week.
10-Mar-2014 - Bristol-Myers Squibb says 160 jobs will be affected in Ireland as changing market demand drives the closure of an API plant.
10-Mar-2014 - Drug excipient makers in India and those serving the market have a dedicated IPEC chapter after the delayed fifth branch of the industry group was finally formally incorporated at the end of January.
03-Mar-2014 - Criminal access to APIs must be cut off in a way that does not infringe generics companies’ right to buy chemicals, a top US prosecutor told In-Pharmatechnologist.com.
27-Feb-2014 - BASF has hiked its prices for ethanolamines in Europe citing continuous demand increase.
Ingredients: Featured news
John Giannone - incoming IPEC-Americas chairman
Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has started a review of its active pharmaceutical ingredient (API) business after competition in the UK impacted its third quarter margins.